This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kakoki, M. Articles by Omata, M. Search for Related Content PubMed PubMed Citation Articles by Kakoki, M. Articles by Omata, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB PHENYLEPHRINE PINDOLOL

(Hypertension. 1999;33:467-471.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Effects of Vasodilatory ß-Adrenoceptor Antagonists on Endothelium-Derived Nitric Oxide Release in Rat Kidney

Masao Kakoki; Yasunobu Hirata; Hiroshi Hayakawa; Hiroaki Nishimatsu; Yasuko Suzuki; Daisuke Nagata; Etsu Suzuki; Kazuya Kikuchi; Tetsuo Nagano; Masao Omata

From the Second Department of Internal Medicine, Faculty of Medicine (M.K., Y.H., H.H., H.N., Y.S., D.N., E.S., M.O.), and Faculty of Pharmaceutical Sciences (K.K., T.N.), University of Tokyo (Japan).

Correspondence to Yasunobu Hirata, MD, The Second Department of Internal Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail hirata-2im{at}h.u-tokyo.ac.jp

Abstract—The mechanisms for the vascular actions of vasodilatory ß-blockers remain undetermined. For some kinds of ß-blockers, the involvement of nitric oxide (NO) has been suggested. We studied the effects of vasodilatory ß-blockers on renal perfusion pressure (RPP) and NO release in the rat kidney. Infusion of bopindolol, celiprolol, and nebivolol caused a dose-dependent reduction in RPP and an increase in NO release (RPP: bopindolol 10^-6 mol/L, -23±2%; celiprolol 10^-4 mol/L, -27±2%; nebivolol 10^-5 mol/L, -35±3%; NO: bopindolol 10^-6 mol/L, +33±2; celiprolol 10^-4 mol/L, +41±2; nebivolol 10^-5 mol/L, +45±5 fmol · min^-1 · g kidney^-1, mean±SEM). Metergoline (10^-6 mol/L), a 5-hydroxytryptamine (5-HT)_1/2 antagonist, or NAN-190 (10^-6 mol/L), a 5-HT_1A antagonist, almost completely abolished the vasorelaxation and NO release caused by bopindolol, celiprolol, and nebivolol. However, neither propranolol nor bisoprolol decreased RPP. Celiprolol and nebivolol caused vasodilation in the rat thoracic aorta, and it was markedly reduced by endothelial denudation, N-nitro-L-arginine methyl ester (10^-4 mol/L), or NAN-190 (10^-6 mol/L). In deoxycorticosterone acetate-salt hypertensive rats, 4-week administration of celiprolol (50 mg · kg^-1 · d^-1 IV) restored the responses regarding RPP and NO release to acetylcholine. These results suggest that several ß-blockers exert their vasodilatory action through the 5-HT_1A receptor/NO pathway and that treatment with these ß-blockers may protect against endothelial injury in hypertension.

Key Words: nitric oxide • kidney • receptors, adrenergic, beta • 5-hydroxytryptamine

This article has been cited by other articles:

				T. Munzel and T. Gori Nebivolol The Somewhat-Different beta-Adrenergic Receptor Blocker. J. Am. Coll. Cardiol., October 13, 2009; 54(16): 1491 - 1499. [Abstract] [Full Text] [PDF]

				A. Maffei and G. Lembo Nitric oxide mechanisms of nebivolol Therapeutic Advances in Cardiovascular Disease, August 1, 2009; 3(4): 317 - 327. [Abstract] [PDF]

				O. Toprak, M. Cirit, M. Tanrisev, C. Yazici, O. Canoz, M. Sipahioglu, A. Uzum, R. Ersoy, and E. Y. Sozmen Preventive effect of nebivolol on contrast-induced nephropathy in rats Nephrol. Dial. Transplant., March 1, 2008; 23(3): 853 - 859. [Abstract] [Full Text] [PDF]

				C. M. McEniery, M. Schmitt, A. Qasem, D. J. Webb, A. P. Avolio, I. B. Wilkinson, and J. R. Cockcroft Nebivolol Increases Arterial Distensibility In Vivo Hypertension, September 1, 2004; 44(3): 305 - 310. [Abstract] [Full Text] [PDF]

				N. Kobayashi, S.-i. Mita, K. Yoshida, T. Honda, T. Kobayashi, K. Hara, S. Nakano, Y. Tsubokou, and H. Matsuoka Celiprolol Activates eNOS Through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-{kappa}B Induced by Oxidative Stress Hypertension, November 1, 2003; 42(5): 1004 - 1013. [Abstract] [Full Text] [PDF]

				L. Kalinowski, L. W. Dobrucki, M. Szczepanska-Konkel, M. Jankowski, L. Martyniec, S. Angielski, and T. Malinski Third-Generation {beta}-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action Circulation, June 3, 2003; 107(21): 2747 - 2752. [Abstract] [Full Text] [PDF]

				M. A. W. Broeders, P. A. Doevendans, B. C. A. M. Bekkers, R. Bronsaer, E. van Gorsel, J. W. M. Heemskerk, M. G. A. o. Egbrink, E. van Breda, R. S. Reneman, and R. van der Zee Nebivolol: A Third-Generation {beta}-Blocker That Augments Vascular Nitric Oxide Release : Endothelial {beta}2-Adrenergic Receptor-Mediated Nitric Oxide Production Circulation, August 8, 2000; 102(6): 677 - 684. [Abstract] [Full Text] [PDF]